본문 바로가기
KERD
논문KCI 등재

Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes

Son Jinsook|Accili Domenico
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 1652-1658|DOI 10.1038/s12276-023-01043-8

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

The maintenance of glucose homeostasis is fundamental for survival and health. Diabetes develops when glucose homeostasis fails. Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell failure. The failure of β-cells to compensate for insulin resistance results in hyperglycemia, which in turn drives altered lipid metabolism and β-cell failure. Thus, insulin secretion by pancreatic β-cells is a primary component of glucose homeostasis. Impaired β-cell function and reduced β-cell mass are found in diabetes. Both features stem from a failure to maintain β-cell identity, which causes β-cells to dedifferentiate into nonfunctional endocrine progenitor-like cells or to trans-differentiate into other endocrine cell types. In this regard, one of the key issues in achieving disease modification is how to reestablish β-cell identity. In this review, we focus on the causes and implications of β-cell failure, as well as its potential reversibility as a T2D treatment.

Abstract

The maintenance of glucose homeostasis is fundamental for survival and health. Diabetes develops when glucose homeostasis fails. Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell failure. The failure of β-cells to compensate for insulin resistance results in hyperglycemia, which in turn drives altered lipid metabolism and β-cell failure. Thus, insulin secretion by pancreatic β-cells is a primary component of glucose homeostasis. Impaired β-cell function and reduced β-cell mass are found in diabetes. Both features stem from a failure to maintain β-cell identity, which causes β-cells to dedifferentiate into nonfunctional endocrine progenitor-like cells or to trans-differentiate into other endocrine cell types. In this regard, one of the key issues in achieving disease modification is how to reestablish β-cell identity. In this review, we focus on the causes and implications of β-cell failure, as well as its potential reversibility as a T2D treatment.

참고문헌 (102)

  1. Heald, A. H., "Estimating life years lost to diabetes : outcomes from analysis of National Diabetes Audit and Office of National Statistics data", Cardiovasc. Endocrinol. Metab, 9, pp.183~185 (2020)
  2. Accili, D., "When beta-cells fail : lessons from dedifferentiation", Diabetes Obes. Metab, 18, pp.117~122 (2016)
  3. Accili, D., "Insulin action research and the future of diabetes treatment : the 2017banting medal for scientific achievement lecture", Diabetes, 67, pp.1701~1709 (2018)
  4. Wang, P., "Human beta cell regenerative drug therapy for diabetes : past achievements and future challenges", Front. Endocrinol. (Lausanne), 12, pp.671946~ (2021)
  5. Weyer, C., "The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2diabetes mellitus", J. Clin. Invest, 104, pp.787~794 (1999)
  6. Talchai, C., "Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure", Cell, 150, pp.1223~1234 (2012)
  7. Amo-Shiinoki, K., "Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes", JCI Insight (2021)[DOI]
  8. Sun, J., "beta-cell dedifferentiation in patients with T2D with adequate glucose control and nondiabetic chronic pancreatitis", J. Clin. Endocrinol. Metab, 104, pp.83~94 (2019)
  9. Cinti, F., "Evidence of beta-cell dedifferentiation in human type 2 diabetes", J. Clin. Endocrinol. Metab, 101, pp.1044~1054 (2016)
  10. Cheng, C. W., "Fasting-mimicking diet promotes Ngn3-driven beta-cell regeneration reverse diabetes", Cell, 168, pp.775~788 (2017)
  11. Wang, Z., "Pancreatic beta cell dedifferentiation in diabetes and redifferentiation following insulin therapy", Cell Metab, 19, pp.872~882 (2014)
  12. Blum, B., "Reversal of beta cell de-differentiation by a small molecule inhibitor of the TGFbeta pathway", eLife, 3, pp.e02809~ (2014)
  13. Brereton, M. F., "Reversible changes in pancreatic islet structure and function produced by elevated blood glucose", Nat. Commun, 5, pp.4639~ (2014)
  14. Ishida, E., "Pair feeding, but not insulin, phloridzin, or rosiglitazone treatment, curtails markers of beta-cell dedifferentiation in db", db mice, 2017, pp.66, 2092~2101
  15. Son, J., "Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of beta-cell failure", Nat. Commun, 14, pp.558~ (2023)
  16. Pia V Röder, "Pancreatic regulation of glucose homeostasis", Experimental and Molecular Medicine, 48, pp.1~19 (2016), 생화학분자생물학회
  17. Haeusler, R. A., "Biochemical and cellular properties of insulin receptor signalling", Nat. Rev. Mol. Cell Biol, 19, pp.31~44 (2018)
  18. Pajvani, U. B., "The new biology of diabetes", Diabetologia, 58, pp.2459~2468 (2015)
  19. Kahn, C. R., "Insulin resistance, insulin insensitivity, and insulin unresponsiveness:a necessary distinction", Metabolism, 27, pp.1893~1902 (1978)
  20. Jung, U. J., "Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease", Int. J. Mol. Sci, 15, pp.6184~6223 (2014)
  21. Bergman, R. N., "Free fatty acids and pathogenesis of type 2 diabetes mellitus", Trends Endocrinol. Metab, 11, pp.351~356 (2000)
  22. Samuel, V. T., "The pathogenesis of insulin resistance : integrating signaling pathways and substrate flux", J. Clin. Invest, 126, pp.12~22 (2016)
  23. Ferrannini, E., "Association of fasting glucagon and proinsulin concentrations with insulin resistance", Diabetologia, 50, pp.2342~2347 (2007)
  24. Ferrannini, E., "The stunned beta cell : a brief history", Cell Metab, 11, pp.349~352 (2010)
  25. Campbell, J. E., "Mechanisms controlling pancreatic islet cell function in insulin secretion", Nat. Rev. Mol. Cell Biol, 22, pp.142~158 (2021)
  26. Liu, M., "Biosynthesis, structure, and folding of the insulin precursor protein", Diabetes Obes. Metab, 20, pp.28~50 (2018)
  27. Sharma, R. B., "Living dangerously: protective and harmful ER stress responses in pancreatic beta-cells", Diabetes, 70, pp.2431~2443 (2021)
  28. Cardozo, A. K., "Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells", Diabetes, 54, pp.452~461 (2005)
  29. Marmugi, A., "Sorcin links pancreatic beta-cell lipotoxicity to ER Ca2+ stores", Diabetes, 65, pp.1009~1021 (2016)
  30. Kaufman, R. J, "Orchestrating the unfolded protein response in health and disease", J. Clin. Invest, 110, pp.1389~1398 (2002)
  31. Sharma, R. B., "Insulin demand regulates beta cell number via the unfolded protein response", J. Clin. Invest, 125, pp.3831~3846 (2015)
  32. Cnop, M., "Endoplasmic reticulum stress and eIF2alpha phosphorylation : The Achilles heel of pancreatic beta cells", Mol. Metab, 6, pp.1024~1039 (2017)
  33. Back, S. H, "Endoplasmic reticulum stress and type 2 diabetes", Annu Rev. Biochem, 81, pp.767~793 (2012)
  34. Mahajan, A., "Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps", Nat. Genet, 50, pp.1505~1513 (2018)
  35. Zhang, Y., "THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic beta-cell function and preserving beta-cell mass", Nat. Commun, 14, pp.1020~ (2023)
  36. Gerber, P. A., "The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus", Antioxid. Redox Signal, 26, pp.501~518 (2017)
  37. Sekine, N., "Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing", J. Biol. Chem, 269, pp.4895~4902 (1994)
  38. Ishihara, H., "Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells", J. Clin. Invest, 104, pp.1621~1629 (1999)
  39. Carlsson, C., "Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro", Endocrinology, 140, pp.3422~3428 (1999)
  40. Li, N., "The sensitivity of pancreatic beta-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress", Biochem Soc. Trans, 36, pp.930~934 (2008)
  41. Matsuoka, T., "Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells", J. Clin. Invest, 99, pp.144~150 (1997)
  42. Harmon, J. S., "Oxidative stress-mediated, posttranslational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells", J. Biol. Chem, 280, pp.11107~11113 (2005)
  43. Martinez-Reyes, I., "Mitochondrial TCA cycle metabolites control physiology and disease", Nat. Commun, 11, pp.102~ (2020)
  44. Maechler, P., "Mitochondrial function in normal and diabetic beta-cells", Nature, 414, pp.807~812 (2001)
  45. Kim, J. A., "Role of mitochondrial dysfunction in insulin resistance", Circ. Res, 102, pp.401~414 (2008)
  46. Anello, M., "Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients", Diabetologia, 48, pp.282~289 (2005)
  47. Shan, Z., "Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment", Aging(Albany NY), 14, pp.2902~2919 (2022)
  48. Bhansali, S., "Alterations in mitochondrial oxidative stress and mitophagy in subjects with prediabetes and type 2 diabetes mellitus", Front Endocrinol. (Lausanne), 8, pp.347~ (2017)
  49. Rottner, A. K., "A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk", Nat. Genet, 55, pp.54~65 (2023)
  50. Park, K., "Lysosomal Ca(2+)-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic beta-cells to metabolic stress", Nat. Commun, 13, pp.1300~ (2022)
  51. Hong Hyun Jung, "Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure", Experimental and Molecular Medicine, 54, pp.1~14 (2022), 생화학분자생물학회[DOI]
  52. Madec, A. M., "Role of mitochondriaassociated endoplasmic reticulum membrane(MAMs)interactions and calcium exchange in the development of type 2 diabetes", Int. Rev. Cell Mol. Biol, 363, pp.169~202 (2021)
  53. Rocha, M., "Mitochondria and T2D : role of autophagy, ER stress, and inflammasome", Trends Endocrinol. Metab, 31, pp.725~741 (2020)
  54. Bensellam, M., "Mechanisms of beta-cell dedifferentiation in diabetes : recent findings and future research directions", J. Endocrinol, 236, pp.R109~R143 (2018)
  55. Jonas, J. C., "Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes", J. Biol. Chem, 274, pp.14112~14121 (1999)
  56. Fiori, J. L., "Resveratrol prevents beta-cell dedifferentiation in nonhuman primates given a high-fat", high-sugar diet, 2013, pp.62, 3500~3513
  57. Chera, S., "Diabetes recovery by age-dependent conversion of pancreatic delta-cells into insulin producers", Nature, 514, pp.503~507 (2014)
  58. Lenz, A., "Redifferentiation of adult human beta cells expanded in vitro by inhibition of the WNT pathway", PLoS One, 9, pp.e112914~ (2014)
  59. Sheng, C., "Reversibility of beta-cell-specific transcript factors expression by long-term caloric restriction in db", db mouse, 2016, pp.2016, 6035046~
  60. Kim-Muller, J. Y., "Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic beta cells in diabetic mice", Nat. Commun, 7, pp.12631~ (2016)
  61. Cabrera, O., "The unique cytoarchitecture of human pancreatic islets has implications for islet cell function", Proc. Natl. Acad. Sci. USA, 103, pp.2334~2339 (2006)
  62. Rodriguez-Diaz, R., "Innervation patterns of autonomic axons in the human endocrine pancreas", Cell Metab, 14, pp.45~54 (2011)
  63. Tong, X., "Lipid droplet accumulation in human pancreatic islets is dependent on both donor age and health", Diabetes, 69, pp.342~354 (2020)
  64. Md Moin, A. S., "Increased frequency of hormone negative and polyhormonal endocrine cells in lean individuals with type 2 diabetes", J. Clin. Endocrinol. Metab, 101, pp.3628~3636 (2016)
  65. Gutierrez, G. D., "Pancreatic beta cell identity requires continual repression of non-beta cell programs", J. Clin. Invest, 127, pp.244~259 (2017)
  66. Gao, T., "Pdx1 maintains beta cell identity and function by repressing an alpha cell program", Cell Metab, 19, pp.259~271 (2014)
  67. Collombat, P., "Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression", J. Clin. Invest, 117, pp.961~970 (2007)
  68. Thorel, F., "Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss", Nature, 464, pp.1149~1154 (2010)
  69. Collombat, P., "The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha subsequently beta cells", Cell, 138, pp.449~462 (2009)
  70. Courtney, M., "The inactivation of Arx in pancreatic alpha-cells triggers their neogenesis and conversion into functional beta-like cells", PLoS Genet, 9, pp.e1003934~ (2013)
  71. Wilcox, C. L., "Pancreatic alpha-cell specific deletion of mouse Arx leads to alpha-cell identity loss", PLoS One, 8, pp.e66214~ (2013)
  72. Zhou, Q., "In vivo reprogramming of adult pancreatic exocrine cells to beta-cells", Nature, 455, pp.627~632 (2008)
  73. Spijker, H. S., "Conversion of mature human beta-cells into glucagonproducing alpha-cells", Diabetes, 62, pp.2471~2480 (2013)
  74. Schmied, B. M., "Transdifferentiation of human islet cells in a long-term culture", Pancreas, 23, pp.157~171 (2001)
  75. Segerstolpe, A., "Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes", Cell Metab, 24, pp.593~607 (2016)
  76. Muraro, M. J., "A single-cell transcriptome atlas of the human pancreas", Cell Syst, 3, pp.385~394 (2016)
  77. Xin, Y., "RNA sequencing of single human islet cells reveals type 2 diabetes genes", Cell Metab (2016)[DOI]
  78. Baron, M., "A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure", Cell Syst, 3, pp.346~360 (2016)
  79. Xin, Y., "Pseudotime ordering of single human beta-cells reveals states of insulin production and unfolded protein response", Diabetes, 67, pp.1783~1794 (2018)
  80. Wang, Y. J., "Single-cell transcriptomics of the human endocrine pancreas", Diabetes, 65, pp.3028~3038 (2016)
  81. Avrahami, D., "Single-cell transcriptomics of human islet ontogeny defines the molecular basis of beta-cell dedifferentiation in T2D", Mol. Metab, 42, pp.101057~ (2020)
  82. Kharchenko, P. V., "Bayesian approach to singlecell differential expression analysis", Nat. Methods, 11, pp.740~742 (2014)
  83. Lahnemann, D., "Eleven grand challenges in single-cell data science", Genome Biol, 21, pp.31~ (2020)
  84. Mawla, A. M., "Navigating the depths and avoiding the shallows of pancreatic islet cell transcriptomes", Diabetes, 68, pp.1380~1393 (2019)
  85. Wang, Y. J., "Single-cell RNA-seq of the pancreatic islets-a promise not yet fulfilled?", Cell Metab, 29, pp.539~544 (2019)
  86. Basso, K., "Reverse engineering of regulatory networks in human B cells", Nat. Genet, 37, pp.382~390 (2005)
  87. Ding, H., "Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm", Nat. Commun, 9, pp.1471~ (2018)
  88. Alvarez, M. J., "Functional characterization of somatic mutations in cancer using network-based inference of protein activity", Nat. Genet, 48, pp.838~847 (2016)
  89. Son, J., "BACH2 inhibition reverses beta cell failure in type 2 diabetes models", J. Clin. Invest (2021)[DOI]
  90. Shapiro, A. M., "Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen", N. Engl. J. Med, 343, pp.230~238 (2000)
  91. Pagliuca, F. W., "Generation of functional human pancreatic beta", Cells Vitr. Cell, 159, pp.428~439 (2014)
  92. Ackeifi, C., "GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration", Sci. Transl. Med (2020)[DOI]
  93. Eliaschewitz, F. G., "Can we prevent beta cell apoptosis in type 2 diabetes?", Diabetes Metab. Res. Rev (2012)[DOI]
  94. Pories, W. J., "Surgical treatment of obesity and its effect on diabetes: 10-y follow-up", Am. J. Clin. Nutr, 55, pp.582S~585S (1992)
  95. Dixon, J. B., "Adjustable gastric banding and conventional therapy for type 2diabetes : a randomized controlled trial", JAMA, 299, pp.316~323 (2008)
  96. Ferrannini, E., "Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes", Diabetes Care, 32, pp.514~520 (2009)
  97. Savage, P. J., "Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus", J. Clin. Endocrinol. Metab, 48, pp.999~1007 (1979)
  98. Taylor, R., "VLCD for weight loss and remission of type 2 diabetes?—authors’reply", Lancet, 392, pp.1307~ (2018)
  99. Taylor, R., "Understanding the mechanisms of reversal of type 2 diabetes", Lancet Diabetes Endocrinol (2019)[DOI]
  100. Harmon, J. S., "Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats", Diabetes, 50, pp.2481~2486 (2001)
  101. Ahuja, M., "Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-Methyl-4-Phenyl-1, 2, 3, 6-tetrahydropyridine-induced experimental Parkinson’s-like disease", J. Neurosci, 36, pp.6332~6351 (2016)
  102. Accili, D., "Reflections on the state of diabetes research and prospects for treatment", Diabetol. Int (2022)[DOI]

관련 논문AI추천

The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities박현준, 이희영, Derek M. Erion생화학분자생물학회 · BMB Reports2016 · 제49권 제3호Recent advances in organoid culture for insulin production and diabetes therapy: methods and challenges김경석, 이수빈, 임경민, 전탁일, 조쌍구, 아브달아메드생화학분자생물학회 · BMB Reports2019 · 제52권 제5호Lin28a ameliorates glucotoxicity-induced β-cell dysfunction and apoptosis이경민, 전원배, 정권수, Yeo Jin Hwang생화학분자생물학회 · BMB Reports2021 · 제54권 제4호Stem Cell Therapy for Type 1 Diabetes Mellitus유은경대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2012 · 제17권 제2호Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes이동윤, 이승아대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2017 · 제22권 제1호2형 당뇨병의 새로운 치료고정민대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2009 · 제14권 제1호

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기